Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-17 RUBINSTEIN JULIE President Sale −5,201 $61.63 $321K 9,799
2021-02-17 RUBINSTEIN JULIE President Sale −9,799 $62.28 $610K 0
2021-02-17 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 315,000
2021-02-16 LO FRANCIS Chief People Officer Option exercise +2,000 $7.80 $16K 2,000
2021-02-16 LO FRANCIS Chief People Officer Sale −2,000 $65.45 $131K 0
2021-02-16 LO FRANCIS Chief People Officer Option exercise · Stock Option (Right To Buy) −2,000 157,000
2021-02-16 RUBINSTEIN JULIE President Option exercise +15,000 $6.55 $98K 15,000
2021-02-16 RUBINSTEIN JULIE President Sale −1,699 $64.78 $110K 13,301
2021-02-16 RUBINSTEIN JULIE President Sale −13,301 $65.31 $869K 0
2021-02-16 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 330,000
2021-02-16 BENZENO SHARON Chief Business Development Off Option exercise +16,250 $31.71 $515K 16,250
2021-02-16 BENZENO SHARON Chief Business Development Off Sale −5,022 $63.42 $318K 11,228
2021-02-16 BENZENO SHARON Chief Business Development Off Sale −1,700 $64.59 $110K 9,528
2021-02-16 BENZENO SHARON Chief Business Development Off Sale −9,528 $65.29 $622K 0
2021-02-16 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −16,250 48,750
2021-02-16 Taylor Stacy L SVP and General Counsel Option exercise +16,250 $31.71 $515K 17,550
2021-02-16 Taylor Stacy L SVP and General Counsel Sale −4,894 $63.43 $310K 12,656
2021-02-16 Taylor Stacy L SVP and General Counsel Sale −2,100 $64.56 $136K 10,556
2021-02-16 Taylor Stacy L SVP and General Counsel Sale −9,256 $65.29 $604K 1,300
2021-02-16 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −16,250 48,750

Page 59 of 120 · 2,386 trades